Reducing dihydrotestosterone in women involves a mix of prescription medications, hormonal therapies, and lifestyle strategies, though the best approach depends on what DHT is actually doing in your body and why it’s elevated. DHT is the most potent androgen circulating in the female body, and even modest excess can drive hair thinning on the scalp, unwanted facial or body hair, and acne. The biology is not identical to what happens in men, and some treatments that work well for male pattern hair loss perform differently in women. That mismatch makes the topic worth looking at carefully.
Why DHT Matters Differently in Women
Testosterone circulates in every woman’s bloodstream, but to affect skin and hair follicles, it has to be converted into DHT by an enzyme called 5-alpha reductase. How much of that conversion happens locally in the skin partly determines androgen sensitivity.1PubMed. Clinical relevance of testosterone and dihydrotestosterone metabolism in women This is why two women can have nearly identical blood testosterone levels and very different symptoms: one may have more active 5-alpha reductase in her scalp or skin follicles than the other.
In women experiencing pattern hair loss, researchers have found that all three known types of 5-alpha reductase can be upregulated in the hair follicle itself, leading to higher local DHT even when blood androgen levels look normal.2The Journal of Clinical Endocrinology & Metabolism. Female Pattern Hair Loss and Androgen Excess: A Report From the Multidisciplinary Androgen Excess and PCOS Committee That localized activity makes the problem harder to detect with routine bloodwork and explains why treatments that work at the tissue level are so important.
There’s an added wrinkle. One study comparing women with pattern hair loss to controls found that their overall DHT production rates were not actually elevated. Instead, testosterone production was higher.3PubMed. Production rates of testosterone and of dihydrotestosterone in female pattern hair loss The authors argued this could mean 5-alpha reductase inhibitors would be less useful in women than in men. But clinical trials have since shown these drugs do help many women, suggesting the picture is more complicated than whole-body production rates capture. Local conversion in the scalp itself appears to be a major player, which standard blood tests for testosterone or even DHT do not reliably reflect.
Prescription 5-Alpha Reductase Inhibitors
Finasteride and dutasteride are the two drugs designed to block 5-alpha reductase directly, cutting off DHT production at the source. Neither is FDA-approved for use in women, but both are prescribed off-label for female pattern hair loss, particularly in postmenopausal women who are not at risk of pregnancy.
In a study of 37 women treated with finasteride for 12 months, about two-thirds showed improvement on global photography, with hair density increasing meaningfully in a subset of patients. Most participants rated their own condition as improved, and none reported adverse reactions during the treatment period.4JAMA Dermatology. Finasteride Treatment of Female Pattern Hair Loss A separate study of postmenopausal women found that 5 mg/day of finasteride was well tolerated, even by those who experienced mild libido changes. Those patients opted to continue treatment because they preferred the side effect to ongoing hair loss.5PubMed Central. Finasteride 5 mg/day Treatment of Patterned Hair Loss in Normo-androgenetic Postmenopausal Women
Dutasteride blocks both type 1 and type 2 forms of the 5-alpha reductase enzyme, while finasteride targets mainly type 2. That broader blockade makes dutasteride more potent for DHT suppression.6PubMed Central. Comparison between dutasteride and finasteride in hair regrowth and reversal of miniaturization in male and female androgenetic alopecia: a systematic review A three-year comparison of both drugs in 120 women found that roughly 82-83% experienced increased hair thickness with either option. Dutasteride performed better than finasteride in women under 50, particularly at the crown and central scalp.7PubMed. The effectiveness of finasteride and dutasteride used for 3 years in women with androgenetic alopecia
The major safety concern with both drugs is teratogenicity. Finasteride and dutasteride can cause birth defects in a male fetus, so they are contraindicated in women who are pregnant or could become pregnant. This is a hard rule, not a precaution. Even handling crushed tablets can cause absorption through the skin. For postmenopausal women or those using reliable contraception, the risk profile is more manageable, but this is the main reason these drugs tend to be second-line rather than first-line treatments in premenopausal women.
Anti-Androgen Medications
Rather than blocking DHT production, anti-androgens work by preventing androgens from binding to their receptors in the skin and hair follicles. Spironolactone is the most commonly prescribed anti-androgen for women. Originally developed as a blood pressure medication, it happens to block androgen receptors as a side effect, which made it a popular off-label choice for acne, hirsutism, and female pattern hair loss.
A systematic review and meta-analysis of spironolactone for female hair loss found an overall improvement rate of about 57%. When spironolactone was combined with other therapies like minoxidil, that rate climbed to about 66%, compared with roughly 43% for spironolactone alone.8PubMed Central. The Efficacy and Safety of Oral Spironolactone in the Treatment of Female Pattern Hair Loss: A Systematic Review and Meta-Analysis Those numbers reflect hair stabilization and visible regrowth combined, so not every woman in the “improved” category saw dramatic new growth.
Bicalutamide, a pure androgen receptor blocker originally developed for prostate cancer, is a newer option gaining traction. A head-to-head trial comparing bicalutamide to spironolactone found that bicalutamide produced a greater increase in hair count at both the frontal scalp and the crown. Side effects were reported in about 12% of the bicalutamide group versus about 19% for spironolactone.9PubMed. Spironolactone vs. bicalutamide in female pattern hair loss: a randomized clinical trial Bicalutamide is still being studied and is not yet widely prescribed for this purpose, but it represents a promising alternative for women who don’t tolerate spironolactone well.
Oral Contraceptives and Hormonal Approaches
Combined oral contraceptives reduce the amount of free testosterone floating around your bloodstream by significantly increasing a protein called sex hormone-binding globulin, or SHBG. SHBG acts like a sponge for androgens, soaking them up so they can’t get converted into DHT or bind to androgen receptors. A systematic review and meta-analysis found that SHBG levels rose substantially during all types of combined oral contraceptive use.10PubMed Central. The effect of combined oral contraception on testosterone levels in healthy women: a systematic review and meta-analysis
The choice of progestin in the pill matters. Some progestins have mild androgenic properties of their own, which can partially work against the anti-androgen benefit. Pills containing anti-androgenic progestins like drospirenone or cyproterone acetate are generally preferred when the goal is DHT reduction. Your prescriber’s choice of formulation can meaningfully shift results. Interestingly, the levonorgestrel intrauterine system, which delivers progestin locally to the uterus, was observed to decrease serum DHT and SHBG levels in one study, which is the opposite effect of combined oral contraceptives.11PubMed. Levonorgestrel effects on serum androgens, sex hormone-binding globulin levels, hair shaft diameter, and sexual function That finding underscores how different hormonal delivery systems can push androgen levels in different directions.
Topical Treatments That Lower DHT Locally
Applying a DHT blocker directly to the scalp is appealing because it targets the tissue where the problem is while limiting how much drug gets into the rest of the body. A randomized controlled trial of postmenopausal women compared a topical solution of 0.25% finasteride combined with 3% minoxidil against minoxidil alone. By 24 weeks, the combination group showed greater improvement in hair diameter, and serum DHT levels dropped in the finasteride group, though they stayed within the normal range throughout the study.12PubMed. Efficacy of Topical Combination of 0.25% Finasteride and 3% Minoxidil Versus 3% Minoxidil Solution in Female Pattern Hair Loss: A Randomized, Double-Blind, Controlled Study
The fact that serum DHT declined even with topical application shows that some systemic absorption does occur. For postmenopausal women, that minor systemic effect is not usually a concern. For premenopausal women, it reintroduces the pregnancy-risk question, albeit at a lower dose. A retrospective comparison of topical finasteride, oral finasteride, and topical minoxidil in postmenopausal women suggested oral finasteride was the most effective across several outcomes, though the differences did not reach statistical significance.13PubMed Central. The Comparative Effects of Monotherapy with Topical Minoxidil, Oral Finasteride, and Topical Finasteride in Postmenopausal Women with Pattern Hair Loss: A Retrospective Cohort Study The takeaway is that topical finasteride is a reasonable option, but the evidence for it being clearly superior to other routes is still developing.
Herbal and Plant-Based Approaches
If you’re looking for non-prescription options, several plant compounds have shown anti-androgenic properties in studies, though the evidence is generally thinner than for the prescription medications above.
Spearmint tea is the most studied herbal option for women specifically. A randomized controlled trial in women with polycystic ovary syndrome found that drinking spearmint tea twice daily for 30 days significantly reduced both free and total testosterone levels.14PubMed. Spearmint herbal tea has significant anti-androgen effects in polycystic ovarian syndrome. A randomized controlled trial An earlier study confirmed that spearmint decreased free testosterone and suggested it could be an alternative to anti-androgenic drugs for mild hirsutism, though total testosterone was not significantly affected in that trial.15PubMed. Effect of spearmint (Mentha spicata Labiatae) teas on androgen levels in women with hirsutism These studies are small and short, but the direction of effect is consistent. Whether the testosterone reduction translates into meaningfully lower DHT at the hair follicle hasn’t been directly measured.
Saw palmetto extract, commonly marketed in hair-loss supplements, has been studied more in men. A systematic review of seven clinical studies found that supplements containing 100 to 320 mg of saw palmetto improved hair quality, total hair count, and hair density across several measures.16PubMed Central. Natural Hair Supplement: Friend or Foe? Saw Palmetto, a Systematic Review in Alopecia Most of those participants were men, so how well these results translate to women is uncertain. Saw palmetto is thought to work through partial 5-alpha reductase inhibition, which is the same mechanism as finasteride, just weaker.
Pumpkin seed oil has shown 5-alpha reductase-blocking and anti-androgenic effects in animal models. A placebo-controlled trial in men with mild to moderate pattern hair loss found that pumpkin seed oil supplementation led to a 40% increase in hair count over 24 weeks, compared to 10% in the placebo group.17PubMed Central. Effect of pumpkin seed oil on hair growth in men with androgenetic alopecia: a randomized, double-blind, placebo-controlled trial A separate mouse study confirmed that topical pumpkin seed oil reversed testosterone-induced hair follicle suppression.18PubMed Central. Beneficial effects of pumpkin seed oil as a topical hair growth promoting agent in a mice model Again, no female-specific clinical trial exists yet, which is a gap worth noting.
Green tea catechins, specifically EGCG, have been reported to selectively inhibit 5-alpha reductase activity and promote hair growth in lab settings.19PubMed. Human hair growth enhancement in vitro by green tea epigallocatechin-3-gallate (EGCG) The evidence here is primarily from cell cultures and animal studies, not from human trials, so it’s premature to treat green tea extract as a proven DHT reducer for women.
Diet, Nutrients, and Insulin Resistance
Insulin resistance is a major driver of androgen excess in women, particularly in those with PCOS. The relationship runs both ways: excess androgens promote insulin resistance, and insulin resistance stimulates more androgen production from the ovaries.20PubMed Central. Association of Insulin Resistance and Elevated Androgen Levels with Polycystic Ovarian Syndrome (PCOS): A Review of Literature Breaking that cycle through diet can reduce the raw material that feeds DHT production.
A study of overweight women placed on a low-glycemic, anti-inflammatory diet with a slight calorie deficit for 60 days found significant drops in total testosterone and the free androgen index, along with a rise in SHBG.21PubMed Central. Reduction in the Free Androgen Index in Overweight Women After Sixty Days of a Low Glycemic Diet Lowering insulin through dietary changes reduces the ovarian signal to produce androgens. For women with PCOS or metabolic syndrome, this kind of dietary shift can complement any medication strategy and sometimes reduces the need for higher drug doses.
Zinc has received attention as a natural 5-alpha reductase inhibitor, and many hair-loss supplements include it for that reason.22PubMed Central. Zinc Status in Kurdish Adults With Hair Loss The evidence that zinc supplementation meaningfully lowers DHT in women who aren’t zinc-deficient is limited, but correcting an actual zinc deficiency could remove one contributor to excess androgen activity. Getting tested before supplementing makes sense, since excess zinc carries its own problems, including copper depletion.
Exercise and Androgen Levels
The relationship between exercise and androgens in women is more nuanced than “exercise lowers DHT.” A study of elite female athletes after a single session of resistance training found significant acute drops in several androgen precursors, including DHEA and androsterone, 60 minutes post-workout. Total bioactive androgens, glucocorticoids, and mineralocorticoids all decreased.23PubMed Central. Acute Adrenal Suppression Following Resistance Training in Elite Female Athletes: A Comprehensive Steroid Profile This was framed as acute adrenal suppression rather than a lasting anti-androgenic benefit, and the participants were elite athletes, not average gym-goers. Still, the finding is consistent with the idea that regular physical activity can modulate the hormonal environment over time, particularly when combined with dietary approaches that improve insulin sensitivity.
Moderate aerobic exercise has been shown in other research to improve insulin sensitivity independently of weight loss, which loops back to the insulin-androgen cycle discussed above. You don’t need to train like an elite athlete. Consistent moderate activity is probably more relevant for long-term androgen management than any single workout’s acute hormonal shift.
The Gut Microbiome and DHT
This is an emerging and genuinely surprising area of research. Studies in mice and humans have found that the gut microbiome plays a role in androgen metabolism. In the distal intestine of mice with normal gut bacteria, free DHT levels exceeded blood serum levels by more than 20-fold. Germ-free mice, raised without any gut bacteria, had very little free DHT in the same location, even though they had similar levels of the inactive, bound form.24PubMed Central. The gut microbiota is a major regulator of androgen metabolism in intestinal contents The implication is that gut bacteria actively strip the glucuronide tag off bound DHT, reactivating it and potentially making it available for recirculation.25Journal of Neurogastroenterology and Motility. Roles of Sex Hormones and Gender in the Gut Microbiota
What this means practically for women trying to lower DHT is still unclear. No clinical trial has tested whether altering the gut microbiome through probiotics, prebiotics, or diet reduces systemic DHT in humans. But the finding opens an interesting door. If certain gut bacteria are reactivating DHT that the liver already inactivated and tagged for excretion, then gut health could be an underappreciated variable in androgen-related conditions. This is worth watching, not worth acting on as a sole strategy.
When Blood Tests Look Normal but Symptoms Don’t
One of the most frustrating experiences for women dealing with androgen-driven hair loss or hirsutism is being told their hormone levels are “normal.” Standard blood panels for testosterone and DHT frequently come back unremarkable even in women with obvious symptoms. A cross-sectional study shed light on why: it found that a metabolite called 3-alpha-androstanediol glucuronide was significantly elevated in women with pattern hair loss compared to controls, while standard androgen markers like total testosterone and DHEAS were abnormal in fewer than 7% of cases. The metabolite correlated with hair loss severity and showed strong diagnostic accuracy as a marker.26PubMed. Evidence of Increased 3-Alpha-Androstanediol Glucuronide in Female Pattern Alopecia: A Cross-Sectional Observational Study Evaluating Ovarian, Adrenal, and Peripheral Androgens
This metabolite is a byproduct of DHT activity in the tissues, so elevated levels indicate that local DHT conversion is happening even when the bloodstream looks calm. If your standard panels have come back normal but you’re still losing hair, asking your doctor about this specific marker could provide a clearer picture. It’s not routinely ordered, which is part of the problem.
Platelet-Rich Plasma as an Adjunct
Platelet-rich plasma therapy involves drawing your blood, concentrating the platelets, and injecting them into the scalp. It does not reduce DHT directly. Instead, the growth factors released by platelets stimulate hair follicle stem cells and promote new blood vessel formation around the follicles.27PubMed Central. Platelet-rich plasma for androgenetic alopecia: A review of the literature and proposed treatment protocol For women already on a DHT-lowering regimen who want additional hair regrowth support, PRP is sometimes used alongside medications like minoxidil or spironolactone. It’s a procedural treatment, typically done as a series of sessions every few weeks, and it’s not covered by insurance. Thinking of it as a DHT strategy would be a mistake, but as a complementary approach to support the follicles you’re trying to protect, it fills a real gap.